These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Prospective study reveals associations between colorectal cancer and type 2 diabetes mellitus or insulin use in men. Campbell PT, Deka A, Jacobs EJ, Newton CC, Hildebrand JS, McCullough ML, Limburg PJ, Gapstur SM. Gastroenterology; 2010 Oct; 139(4):1138-46. PubMed ID: 20633560 [Abstract] [Full Text] [Related]
4. Impact of body mass index on survival after colorectal cancer diagnosis: the Cancer Prevention Study-II Nutrition Cohort. Campbell PT, Newton CC, Dehal AN, Jacobs EJ, Patel AV, Gapstur SM. J Clin Oncol; 2012 Jan 01; 30(1):42-52. PubMed ID: 22124093 [Abstract] [Full Text] [Related]
6. Type 2 diabetes mellitus, insulin-use and risk of bladder cancer in a large cohort study. Newton CC, Gapstur SM, Campbell PT, Jacobs EJ. Int J Cancer; 2013 May 01; 132(9):2186-91. PubMed ID: 23024033 [Abstract] [Full Text] [Related]
7. Active smoking and mortality among colorectal cancer survivors: the Cancer Prevention Study II nutrition cohort. Yang B, Jacobs EJ, Gapstur SM, Stevens V, Campbell PT. J Clin Oncol; 2015 Mar 10; 33(8):885-93. PubMed ID: 25646196 [Abstract] [Full Text] [Related]
9. Following cancer prevention guidelines reduces risk of cancer, cardiovascular disease, and all-cause mortality. McCullough ML, Patel AV, Kushi LH, Patel R, Willett WC, Doyle C, Thun MJ, Gapstur SM. Cancer Epidemiol Biomarkers Prev; 2011 Jun 10; 20(6):1089-97. PubMed ID: 21467238 [Abstract] [Full Text] [Related]
10. [A prospective cohort study on body mass index and mortality among middle-aged and elderly men in urban Shanghai]. Wang J, Gao YT, Wang XL, Liu EJ, Zhang YL, Yuan JM. Zhonghua Liu Xing Bing Xue Za Zhi; 2005 Jun 10; 26(6):394-9. PubMed ID: 16185443 [Abstract] [Full Text] [Related]
11. Diabetes mellitus and risk of colorectal cancer: a meta-analysis. Larsson SC, Orsini N, Wolk A. J Natl Cancer Inst; 2005 Nov 16; 97(22):1679-87. PubMed ID: 16288121 [Abstract] [Full Text] [Related]
13. The joint effects of different types of glucose-lowering treatment and duration of diabetes on total and cardiovascular mortality among subjects with type 2 diabetes. Khalangot M, Tronko M, Kravchenko V, Kulchinska J, Hu G. Diabetes Res Clin Pract; 2008 Oct 16; 82(1):139-47. PubMed ID: 18703252 [Abstract] [Full Text] [Related]
14. Clinically confirmed type 2 diabetes mellitus and colorectal cancer risk: a population-based, retrospective cohort study. Limburg PJ, Vierkant RA, Fredericksen ZS, Leibson CL, Rizza RA, Gupta AK, Ahlquist DA, Melton LJ, Sellers TA, Cerhan JR. Am J Gastroenterol; 2006 Aug 16; 101(8):1872-9. PubMed ID: 16790032 [Abstract] [Full Text] [Related]
18. Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people. Schramm TK, Gislason GH, Køber L, Rasmussen S, Rasmussen JN, Abildstrøm SZ, Hansen ML, Folke F, Buch P, Madsen M, Vaag A, Torp-Pedersen C. Circulation; 2008 Apr 15; 117(15):1945-54. PubMed ID: 18378618 [Abstract] [Full Text] [Related]